David S. Han

Family Medicine
1901 Broadview Dr
Glendale, CA 91208

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications

Bioequivalence of budesonide/glycopyrrolate/formoterol fumarate with a next-generation propellant versus hydrofluoroalkane-134a in healthy adults: phase I, randomized, double-blind, single-dose, partial-replicate, three-way cross-over lung exposure and total systemic exposure studies.

Bioequivalence of budesonide/glycopyrrolate/formoterol fumarate with a next-generation propellant versus hydrofluoroalkane-134a in healthy adults: phase I, randomized, double-blind, single-dose, partial-replicate, three-way cross-over lung exposure and total systemic exposure studies.

Journal: Therapeutic advances in respiratory disease
Published: February 12, 2026

Open Proximal Hamstring Repair Using All-Suture Anchors and Tension-Slide Fixation.

Open Proximal Hamstring Repair Using All-Suture Anchors and Tension-Slide Fixation.

Journal: Arthroscopy techniques
Published: June 17, 2025

Pharmacokinetics and Tolerability of the Novel Myeloperoxidase Inhibitor Mitiperstat in Healthy Japanese and Chinese Volunteers.

Pharmacokinetics and Tolerability of the Novel Myeloperoxidase Inhibitor Mitiperstat in Healthy Japanese and Chinese Volunteers.

Journal: Clinical drug investigation
Published: October 14, 2024

Percutaneous Achilles Repair With High-Strength Suture Tape Augmentation: A Technical Note.

Percutaneous Achilles Repair With High-Strength Suture Tape Augmentation: A Technical Note.

Journal: Arthroscopy techniques
Published: September 02, 2024

Evaluation of a stabilized RSV pre-fusion F mRNA vaccine: Preclinical studies and Phase 1 clinical testing in healthy adults.

Evaluation of a stabilized RSV pre-fusion F mRNA vaccine: Preclinical studies and Phase 1 clinical testing in healthy adults.

Journal: Vaccine
Published: March 23, 2023

AZD8233 antisense oligonucleotide targeting PCSK9 does not prolong QT interval.

AZD8233 antisense oligonucleotide targeting PCSK9 does not prolong QT interval.

Journal: British journal of clinical pharmacology
Published: February 22, 2022

A phase 1 study to evaluate the safety, tolerability and pharmacokinetics of TAK-041 in healthy participants and patients with stable schizophrenia.

A phase 1 study to evaluate the safety, tolerability and pharmacokinetics of TAK-041 in healthy participants and patients with stable schizophrenia.

Journal: British journal of clinical pharmacology
Published: September 28, 2021

Pharmacokinetics, Pharmacodynamics, and Tolerability of AZD5718, an Oral 5-Lipoxygenase-Activating Protein (FLAP) Inhibitor, in Healthy Japanese Male Subjects.

Pharmacokinetics, Pharmacodynamics, and Tolerability of AZD5718, an Oral 5-Lipoxygenase-Activating Protein (FLAP) Inhibitor, in Healthy Japanese Male Subjects.

Journal: Clinical drug investigation
Published: August 31, 2021

Dapagliflozin Added to Verinurad Plus Febuxostat Further Reduces Serum Uric Acid in Hyperuricemia: The QUARTZ Study.

Dapagliflozin Added to Verinurad Plus Febuxostat Further Reduces Serum Uric Acid in Hyperuricemia: The QUARTZ Study.

Journal: The Journal of clinical endocrinology and metabolism
Published: June 29, 2020

Early Clinical Experience With AZD4831, A Novel Myeloperoxidase Inhibitor, Developed for Patients With Heart Failure With Preserved Ejection Fraction.

Early Clinical Experience With AZD4831, A Novel Myeloperoxidase Inhibitor, Developed for Patients With Heart Failure With Preserved Ejection Fraction.

Journal: Clinical and translational science
Published: April 09, 2020
Showing 1-10 of 10

Last Updated: 09/26/2026